FILTER
FILTERED ARTICLE RESULTS
R&D: Is Innovation Really Happening in China?
August 09, 2018
With an ever-increasing stockpile of innovative technologies and a growing network of talented scientists intently focused on innovation, it will merely be a matter of time before China begins to produce some of the most cutting-edge drugs.
Patient Selection: The Right Drug for the Right Patient
June 06, 2018
By better defining addressable patient populations and more precisely predicting likely individual responses, companies are able to reduce a great deal of risk in their clinical trials.
Infectious Diseases: Addressing Growing Resistance
April 26, 2018
The infectious disease space is one of high unmet need. However, this particular market segment carries an additional challenge: drug resistance.
Finding Funding: The Diversification of the Biotech Financing Landscape
March 27, 2018
The methods of financing biotech R&D are evolving as large pharma companies and governments look to small biotech start-ups to provide the next generation of medicines.
The Winning Formula: Building the Number One Biopharmaceutical Supercluster
February 22, 2018
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.
Raising the bar: India’s generic players compete for market share
November 24, 2017
As India’s domestic pharmaceutical market becomes increasingly crowded and the industry as a whole continues along the path of globalization, ...
Building Blocks: Bulk Drugs, Excipients and Intermediates
October 19, 2017
The largest supplier of generic drugs globally, India continues to fortify its reputation as a hub for the production of affordable quality medicines.
Introducing India’s Pharmaceutical Industry
September 06, 2017
The largest supplier of generic drugs globally, India continues to fortify its reputation as a hub for the production of affordable quality medicines.
Quality: A Means for Value Creation
June 19, 2017
Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2024
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
